by Kim Engqvist | Apr 13, 2021 | In the News
The Cell & Gene Meeting is organized by the Alliance for Regenerative Medicine. This year featuring more than 90 company presentations by leading public and private companies, highlighting technical and clinical achievements over the past 12 months in the areas...
by Kim Engqvist | Mar 15, 2021 | In the News, Press Releases
The shareholders in Amniotics AB (publ), org. No. 559024-6558 (“Amniotics”), is hereby called to the Annual General Meeting on Thursday, April 15, 2021. View all...
by Kim Engqvist | Jun 22, 2020 | Press Releases
Kåre Engkilde, Chief Executive Officer, plans to present an overview of the company and provide a business update at the upcoming Virtual European Biotech Investor Day 2020 hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq. During the 30 (public...
by Kim Engqvist | Apr 1, 2020 | In the News
Amniotics™ is currently trying to help the local community as much as possible in the coronavirus crisis. We are donating our protective clothing that we use in our GMP laboratory to Region Skåne. These clothes, designed to minimize spread of particles are only used...
by Kim Engqvist | Mar 18, 2020 | Press Releases
Longboat Amniotics AB has changed its name to Amniotics AB, to emphasize our commitment to developing innovative and life-changing treatments based on our cell-based products from amniotic fluid. Our pipeline of cell-therapeutics is based on Mesenchymal Stem Cell,...
Recent Comments